UNC Lineberger Newsroom

UNC Lineberger is proud to be a part of the dynamic changes and advancements in cancer treatment, research and prevention.

One of the leading cancer centers in the nation, UNC Lineberger Comprehensive Cancer Center is located in Chapel Hill, North Carolina.  As one of only 41 National Cancer Institute-designated Icon indicating that a link will open an external site. comprehensive cancer centers, UNC Lineberger is rated as exceptional, the highest category, by the National Cancer Institute.  The center brings together some of the most exceptional physicians and scientists in the country to investigate and improve the prevention, early detection and treatment of cancer.

To contact the UNC Health Care or UNC School of Medicine newsroom, please click here.

Latest News from UNC Lineberger
Over 20 UNC Cancer Care doctors named to 2015 Newsweek Top Cancer Doctors list
Newsweek, in conjunction with Castle Connolly Medical LTD, has published its list of the “Top Cancer Doctors in the United States for 2015.” UNC Lineberger is proud to announce that 22 of those physicians listed are affiliated with UNC Cancer Care.
Scientists identify gene vital for rebuilding intestine after cancer treatment
Protecting the gastrointestinal system during chemotherapy or radiation could allow patients to tolerate more aggressive treatments to attack tumors.
UNC Lineberger research director Michele Hayward honored as Hometown Hero
Michele Hayward, a research director at UNC Lineberger, was honored on Monday by 97.9 WCHL Chapelboro.com with the Hometown Heroes Award.
UNC jumps another 6 slots in 2015–16 U.S. News & World Report cancer rankings
UNC Hospitals is once again nationally ranked in cancer, taking the 32nd spot in the country in a U.S. News & World Report ranking of over 900 hospitals across the country. The latest ranking is up from 38th in 2014 and 43rd in 2013.
Carey and Perou publish editorial in New England Journal of Medicine
Lisa Carey, MD, medical director of the UNC Breast Center, division chief of hematology and oncology at the UNC School of Medicine, and physician-in-chief of the N.C. Cancer Hospital and Chuck Perou, PhD, the May Goldman Shaw Distinguished Professor of Molecular Oncology, have published an editorial in the July 16 issue of The New England Journal of Medicine entitled “Palbociclib — Taking Breast-Cancer Cells Out of Gear.”